13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 46 holding rows worth $1,290,660,572.
- Accession
- 0000919574-23-001552
- Filer
- CIK 1534261
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 46 entries on the cover page, a total value of $1,290,660,572 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,290,660,572 with VALUE read as dollars as filed, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,315,000 | $170,397,700 | dollars as filed | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 7,566,292 | $137,735,266 | dollars as filed | |
| EQRX INC | 26886C107 | COM | 39,527,669 | $97,238,066 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 365,000 | $86,742,250 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 385,000 | $77,847,000 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 1,477,800 | $64,742,418 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,525,000 | $60,145,500 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 9,505,000 | $51,897,300 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 3,030,648 | $45,277,881 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 2,290,571 | $44,322,549 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,300,000 | $36,153,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,675,000 | $32,377,750 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 12,604,275 | $31,636,730 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 565,000 | $27,973,150 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 2,270,000 | $22,995,100 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 945,000 | $22,500,450 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 475,000 | $21,522,250 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,050,000 | $20,684,500 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 850,000 | $18,861,500 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 1,850,000 | $17,334,500 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 9,038,388 | $16,811,402 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 150,000 | $16,500,000 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 3,206,380 | $16,448,729 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 7,363,260 | $15,462,846 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 370,000 | $14,470,700 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 630,000 | $13,992,300 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 734,350 | $13,644,223 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 6,078,860 | $12,218,509 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 60,000 | $10,777,200 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 295,000 | $10,292,550 | dollars as filed | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 50,000 | $8,069,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 200,000 | $6,842,000 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 77,500 | $6,224,800 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 30,000 | $5,388,600 | dollars as filed | call |
| DICE THERAPEUTICS INC | 23345J104 | COM | 165,000 | $5,148,000 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 100,000 | $4,531,000 | dollars as filed | call |
| OPTIMIZERX CORP | 68401U204 | COM NEW | 260,000 | $4,368,000 | dollars as filed | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 16,437,500 | $4,336,213 | dollars as filed | |
| DEFINITIVE HEALTHCARE CORP | 24477E103 | CLASS A COM | 360,000 | $3,956,400 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 510,882 | $3,887,812 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 65,000 | $3,121,300 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 1,345,722 | $2,704,901 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 200,000 | $1,400,000 | dollars as filed | |
| EXSCIENTIA PLC | 30223G102 | ADS | 213,900 | $1,140,087 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 206,415 | $338,521 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 123,839 | $200,619 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-23-001552 | this filing | 2023-02-14 | acceptance time not in the bulk data set |